Venmax Drugs & Pharmaceuticals Inc — Quarterly Results & Earnings

₹25.77

-2.15%

Profit Growth YoY106.67%Latest quarter

Sales Growth YoY676.47%Latest quarter

Sales CAGR 5Y11.50%5 year compound

Profit CAGR 5Y19.57%5 year compound

📋

Quarterly Performance

YoY Profit Growth+106.67%

🔥 Exceptional growth

YoY Sales Growth+676.47%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

19.57%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

6.38%

ROCE

5.29%

💡

Growth Analysis

Venmax Drugs & Pharmaceuticals Inc reported YoY profit growth of 106.67% and revenue growth of 676.47% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 11.50% and profits at 19.57% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Venmax Drugs & Pharmaceuticals Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.